| Abstract
Leukemia is a cancer, which is derived from leukocytes and precursors of
leukocytes in the bone marrow. A large number of pivotal biological processes
are linked to leukemia pathogenesis. More insights into these mechanisms can
provide a better developing pharmacological platform for patients with
leukemia. Among the different players in leukemia pathogenesis, exosomes
have appeared as a new biological vehicle, which can transfer oncogenic signals
to blood cells. Exosomes are nano‐carriers, which enable transferring numerous
cargos such as DNA fragments, RNAs, messenger RNAs, microRNAs, long
noncoding RNA, and proteins. Targeting the contents of exosomes leads to the
alteration of host cell behavior. Increasing evidence has indicated that
leukemia‐derived exosomes could be utilized as prognostic, diagnostic, and
therapeutic biomarkers for individuals suffering from leukemia. In this regard,
the importance of exosomes in terms of initiation and progression of leukemia
was underlined in this study. |